DISH New
DISH New
DISH New
net/publication/258281357
CITATIONS READS
121 2,529
3 authors, including:
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by J.J. Verlaan on 07 August 2014.
Introduction
Diffuse idiopathic skeletal hyperostosis (DISH) is a direct consequence of DISH, bone depositions may lead
poorly understood, systemic condition characterized by to biomechanical changes of the musculoskeletal system
progressive calcification and ossification of ligaments and/or the formation of obstructive cervical masses.6,7
and entheses. Although the first description of DISH (by In this Review, the current understanding of DISH is
Forestier and Rotes-Querol using the dated term ‘anky- discussed with a special focus on epidemiology, aeti-
losing hyperostosis’) dates back to 1950,1 a large body of ology, clinical manifestations and treatment options.
evidence shows DISH to be of more ancient origin.2 The Furthermore, the present criteria for the definition of
formal diagnosis of DISH is established when simple DISH are scrutinized, and suggestions for a new and
descriptive morphological abnormalities of the thoracic improved version proposed.
spine are observed radiologically (Figure 1). Several
names have been previously proposed for the collection Epidemiology
of these features, including senile vertebral ankylos- Historical notes
ing hyperostosis, spondylitis deformans, spondylosis Macroscopic examinations of skeletal remains from
hyperostotica and spondylitis ossificans ligamentosa.3 humans living in medieval and more ancient times
However, the generally accepted current name—diffuse show DISH to be particularly prevalent in individuals
idiopathic skeletal hyp erostosis—better reflects the of high social status, even when taking into account
Rheumatic Diseases
systemic nature of the condition and the paucity of the long evity of elite groups. 8,9 Features suggestive Unit, Ha’Emek Medical
knowledge regarding its aetiology. of DISH have also been found in the skeleton of the Centre, Afula 18101,
Israel (R. Mader).
Because DISH is a largely asymptomatic condition, Egyptian pharaoh Ramses II and in Neanderthals living University Medical
with most affected individuals not aware of its presence, 50,000 years ago.10,11 Factors suggested to have contrib- Centre Utrecht,
it has not received much attention from clinicians and uted to the development of DISH in privileged ancient 3584 CX Utrecht,
The Netherlands
researchers. In addition, some studies have suggested that individuals include a protein-rich diet, sedentary work (J.‑J. Verlaan).
DISH is of little clinical relevance.4 Increasing evidence, and obesity.12 The marked prevalence of DISH in medi- Department of
Medicine, H. Soroka
however, shows DISH to be an indicator for a number eval clergymen prompted some authors to relate the Medical Centre, Ben
of pathological conditions. The presence of DISH may development of DISH to ‘a monastic way of life’ and Gurion University of the
indicate underlying metabolic derangement and is view it as an ‘occupational disease’.13,14 However, as cri- Negev, Beer Sheva
84101, Israel
associated with cardiovascular disease.5 Moreover, as a teria to establish the diagnosis of DISH have not always (D. Buskila).
been applied uniformly (currently the classification
Correspondence to:
Competing interests by Resnick et al.3 from 1976 is most commonly used R. Mader
The authors declare no competing interests. to define the disease), some caution is advised when [email protected]
Clinical manifestations
Spinal involvement
Radiological characteristics
DISH is a condition that mainly affects the elderly popu-
lation. DISH has some peculiarities that allow its charac
terization as a distinct clinical entity and differentiate
it from spondylosis.22 First, unlike spondylosis, DISH
frequently (and to date by definition) involves the tho-
racic spine, which is not usually involved in spondylosis
until late stages. Second, the intervertebral disc height
is usually preserved in patients with DISH, whereas it is
reduced in individuals with spondylosis.3 These differ-
ences are probably a result of the different targets of the
pathological processes. Indeed, in spondylosis, the main
target is the cartilage of the intervertebral discs, whereas
in DISH the target is the enthesis (with sparing of the
Figure 1 | The characteristic radiological features of DISH. intervertebral discs).3,23 Third, the osteophytes in spon-
a | Right-sided flowing osteophytes connecting thoracic dylosis are usually transverse, whereas the osteophytes in
vertebrae. b | Ossification of the anterior longitudinal DISH are coarse, vertical and bridging. Last, involvement
ligament. Abbreviation: DISH, diffuse idiopathic of the mobile cervical and lumbar spine in spondylosis is
skeletal hyperostosis. usually limited to the lower portions of these segments,
whereas in DISH the involvement is more extensive
comparing the results from older studies. Some histori- and can be associated with various complications.24,25
cal studies tentatively link DISH to physical impairment, Intervertebral disc lesions are as frequent in patients with
although these reports must be regarded as of mainly DISH as in patients with other conditions; however, they
anecdotal value.9, 15 tend to occur at an earlier age in patients with DISH.26
One unanswered question is what effect these changes pathogenesis. Moreover, familial clustering of the condi-
have on the clinical presentation of DISH. It could be tion and early onset (in the third decade of life) in some
assumed that damaged joints with OA‑like lesions will affected families have been observed, which are also
be painful. However, few controlled studies have been suggestive of a genetic contribution to the disease.50,51
conducted to assess pain in hyperostotic peripheral joints, Studies in dogs have revealed the overall prevalence of
and they have yielded conflicting results. For example, canine DISH to be 3.8%, whereas in the Boxer breed it is
elbow pain was only slightly more prevalent in patients >40%, which further supports the existence of a genetic
with hyperostosis of the elbow (n = 48) than in controls component in the risk of developing DISH. 52 So far,
without elbow hyperostosis (n = 24); thus, this radiologi- however, only one potential susceptibility gene (namely
cal finding was considered to be of questionable clinical COL6A1, which encodes type VI collagen α chain) has
relevance.4 By contrast, the same group of investigators been identified.
concluded that shoulder hyperostosis in patients with Single nucleotide polymorphisms in COL6A1 have
DISH is a potential cause of pain.43 Thus, although the been reported in Japanese but not Czech patients with
clinical impact of hyperostosis in peripheral joints is not DISH.53,54 COL6A1 is also a known susceptibility gene
yet clear, limited range of motion and pain in OA‑atypical for ossification of the posterior longitudinal ligament
sites may draw attention to the possibility of DISH. (OPLL), a disorder that is closely associated with and
As mentioned above, calcification and ossification of can coexist with DISH. OPLL usually involves the cervi-
peripheral entheses, such as those in the heel, ribs and cal spine and, similarly to DISH, it affects the elderly,
pelvis, have been frequently observed in patients with more often males, and has been reported to be associated
DISH.46,47 Although some physicians have suggested the with low glucose tolerance and obesity.55 Nonetheless,
inclusion of symmetrical large enthesophytes in the clas- the association between COL6A1 variants and DISH was
sification of DISH, no studies have validated this pro- stronger among patients with DISH without OPLL than
posal.12,28 The clinical significance of these enthesopathies in patients with concomitant DISH and OPLL, suggest-
is not clear, although in our experience the entheses can ing that OPLL associated with DISH might differ from
become tender and swollen. In a comparison of abnor- the common form of isolated OPLL.
malities at 14 pelvic sites in patients with DISH (n = 93) The protein encoded by COL6A1, type VI collagen α
versus patients with moderate to severe spondylosis, ossi- chain, is an extracellular matrix protein that might serve
fication of the iliolumbar, sacrotuberous, and sacroiliac as a scaffold for osteoblastic or pre-osteoblastic cells or
ligaments, with enthesophytic overgrowth at the lesser chondrocytes that subsequently proceed to membra-
trochanter, proved to be significant in distinguishing nous or endochondral ossification.54 Thus, although the
between these entities.48 effects of COL6A1 variants on bone metabolism have not
been elucidated, it has been suggested that this protein
Heterotopic ossification might be involved in ectopic bone formation in DISH
Reflecting the systemic bone-forming nature of the and OPLL.
disease, patients with DISH have a greater propensity
than control individuals to develop heterotopic ossi- Metabolic factors
fications in response to local events, including joint Although DISH is a musculoskeletal condition, it has
replacement surgery.24 In some cases, these ossifications to be viewed as a systemic disease and has often been
can impair the proper functioning of the affected joint, linked to metabolic and constitutional factors, many of
and prophylactic treatment with irradiation or NSAIDs which form part of the metabolic syndrome.5 Indeed,
is indicated in these patients. It is currently not known DISH has been reported to be associated with obesity,
what causes the formation of heterotopic ossifications, high waist-to-hip circumference ratio, dyslipidemia,
although some physicians have speculated, having hypertension, glucose intolerance, type 2 diabetes,
observed the reoccurrence of these ossifications after hyperuricaemia, hyperinsulinaemia and possibly ele-
surgical resection, that the surgical trauma itself induces vated growth hormone and insulin-like growth factor 1
ossification through as yet unknown pathways.49 (IGF‑1) levels.56–61 Owing to these metabolic derange-
ments, patients with DISH have an increased likeli-
Aetiology and pathogenesis hood of being affected by metabolic syndrome and an
The aetiology and pathogenesis of DISH are far from increased risk for the development of coronary artery
clear. However, DISH has to be considered a bone- disease and stroke.5,62
forming disease. Indeed, the hallmark of the condition is Excess body weight has been reported in patients with
new bone formation, in bones and especially in entheses. DISH since the early description by Forestier,1 and this
The enthesis is composed of fibroblasts, chondrocytes, finding has been reiterated in other studies.30,63 Moreover,
collagen fibres and calcified matrix; these components DISH has been associated with type 2 diab etes, 60
might be influenced by various mediators that can although other investigators have questioned the asso-
promote new bone formation in these sites. ciation.64 Both excess body weight and type 2 diabetes
are often accompanied by hyperinsulinaemia, which has
Genetic factors also been reported in patients with DISH.56–58,65–67 Insulin
The variation in the prevalence of DISH throughout the has been shown to promote the differentiation of mesen-
world suggests that genetic factors might play a part in its chymal cells into chondrocytes in vitro,68 suggesting that
fibroblasts and chondrocytes and by increasing ALP this segment of the spine. However, a lack of mobility
activity (Figure 3).84,85 The activity of BMP2 is inhibited cannot explain the involvement of more mobile seg-
by matrix Gla protein (MGP), and therefore deficiency ments, such as the cervical or lumbar spine, and further
of MGP or its defective carboxylation increases levels of studies are needed to solve this discrepancy.
active BMP2, with resultant excess new bone forma-
tion.61,86 Upregulation of the expression of BMP2 and Peripheral mechanisms
BMP4 mRNA has been observed following mechanical Mechanisms that underlie the pathogenesis of hyper-
stress in spinal ligament cells from patients with OPLL,87 trophic OA‑like changes in peripheral joints and the
and thus it is possible that this pathway might also be involvement in DISH of peripheral joints not typi-
involved in the ossification process in DISH. cally affected in primary OA have not been elucidated.
Beyond the hyperostotic processes described above, it
PGI2 and endothelin 1 has been suggested that these manifestations of DISH
Prostaglandin I2 (PGI2) is a potent inhibitor of bone might result from stiffening of capsules and ligaments
resorption, and endothelin 1 is a potent vasoactive around the joints and, as a result, increased intra-
peptide that might regulate ectopic calcification of the articular pressure.92 Further research will be needed to
vasculature. Besides its endothelial expression, endothe- confirm this hypothesis, as well as to elucidate the spinal
lin 1 is reportedly expressed in osteocytes, osteoblasts mechanisms of ossification, if we are to fully understand
and osteoclasts, and it may regulate the proliferation of the pathogenesis of DISH.
these cells.89,90 In vitro studies of cells harvested during
surgery from patients with OPLL and from control Diagnosis
individuals showed that mechanical stress on OPLL Classification criteria
cells can enhance the production of PGI2 and endo Several sets of classification criteria have been proposed
thelin 1.88,89 Both of these molecules can induce, through for DISH (Table 1). The 1976 Resnick and Niwayama
various mechanisms, ALP activity and osteogenic criteria 3 require either ‘flowing’ coarse osteophytes
differentiation in spinal ligament cells. Endothelin 1 can connecting at least four contiguous vertebrae or ossi-
exert its activity directly by increasing the expression of fication of the anterior longitudinal ligament, together
osteogenic marker genes, such as those encoding ALP, with preserved intervertebral height and an absence of
type I collagen and osteocalcin. Furthermore, it can act apophyseal joint or sacroiliac joint (SIJ) involvement.3
indirectly by upregulating PGI2 expression (Figure 3).88,89 In 1985, Arlet and Mazieres93 lowered the threshold
It has been speculated that endothelin 1 and PGI2 might for the number of vertebrae bridged by flowing osteo-
have roles in the pathogenesis of DISH, although this phytes to three vertebrae in the lower thoracic spine. In
hypothesis awaits confirmation. their criteria, ossifications in the vicinity of the SIJ or
iliolumbar ligament are allowed, as long as the SIJ
Vascular and mechanical factors surface is not involved.93 Also in 1985, Utsinger further
One of the intriguing questions about DISH is the predi- extended the classification criteria to include peripheral
lection for ossification of the anterolateral aspect of the enthesopathies.28 Using these criteria, a definite DISH
thoracic spine. Interestingly, involvement of the left side diagnosis can be established when thoracolumbar ossi-
of the thoracic spine has been described in a few case fication of at least four contiguous vertebrae is present;
reports of patients with a right-sided aorta, suggesting a probable diagnosis can be considered when two con-
that aortic pulsations prevent the characteristic enthe- tiguous vertebrae are involved and bilateral peripheral
seal calcification and ossification observed in DISH.91 In enthesopathies are also observed; and a possible diagno-
addition, the limited mobility of the thoracic spine has sis can be considered either when two contiguous verte-
been suggested to be responsible for the predilection to brae are involved or when symmetrical enthesopathies
are observed in the absence of spinal involvement (in Box 1 | Suggested therapeutic interventions in DISH
particular when they affect more than one anatomical
■■ Weight reduction and physical activity
site). The probable and possible categories may iden-
■■ Physical therapy
tify sets of patients who are more likely to have DISH ■■ Diet low in saturated fat and carbohydrate
or develop DISH later on in life, although currently ■■ Instruction in joint-protection techniques
there is no known established practical approach to ■■ Entheseal protection and local corticosteroid infiltration
the management of these patients. The exclusion cri- ■■ Local application of NSAIDs or capsaicin
teria proposed by Utsinger were abnormal disc space ■■ Analgesics
height and apophys eal joint ankylosis. 28 Another set ■■ Systemic NSAIDs
■■ Avoidance of thiazide diuretics and β‑adrenergic
of classification criteria was suggested by Rogers and
antagonists
Waldron.14 Again, the mandatory criteria for the diagno- ■■ Prevention of accidental falls and aspiration pneumonia
sis of DISH were right-sided hyperostosis of the thoracic ■■ Prevention of post-surgical heterotopic ossification
vertebrae associated with extraspinal and/or entheseal ■■ Surgical resection of cervical osteophytes (in extreme
calcification and ossification (Table 1).14 A study of the cases)
human skeletal remains of 253 individuals found dif- Abbreviation: DISH, diffuse idiopathic skeletal hyperostosis.
ferences in the prevalence of definite DISH depending
on the criteria used. The prevalence ranged from 5.5%
by the Resnick criteria to 17% by the Rogers criteria. rate of new bone formation is similar to that observed
The extraspinal enthesophytes were found to be unreli in AS.34 Therefore, given the lack of disease-modifying
able in predicting DISH.2 None of the criteria sets used therapeutics, the treatment of DISH should be directed
so far attempted to incorporate the constitutional and towards the musculoskeletal manifestations, the associ-
metabolic derangements reported in DISH. ated metabolic and constitutional co-morbidities, and
the complications of the condition (Box 1).
Differential diagnosis
Owing to inconsistencies in the literature and a paucity Treatment of pain
of well-designed studies, no agreement has been Physical therapy to preserve mobility and alleviate pain
reached regarding the incorporation of clinical symp- is thought to be a reasonable approach. However, a
toms, extraspinal manifestations or associated con- small study on the effect of exercise therapy in patients
stitutional and metabolic conditions in the diagnosis with DISH did not show a significant improvement
of DISH.94 Other diseases that exhibit excessive bone in the range of spinal motion, except for lumbosacral
formation and entheseal involvement should be consid- flexion.97 A beneficial effect of chiropractic management
ered before a diagnosis of DISH is established. Being a was reported only in two case reports.98,99 By contrast,
disease most commonly observed in elderly individuals, a small uncontrolled study reported that patients with
DISH may frequently coexist with spondylosis and OA. DISH who have musculoskeletal pain could benefit from
Distinguishing between these entities is not always easy treatment with NSAIDs or heat therapy.100
but can be achieved by considering the different spinal The peripheral joints in patients with DISH are
and extraspinal manifestations (see above). DISH also affected in a similar manner to those in patients with OA
shares features with AS, including a tendency for ossi- (although with hypertrophic changes or the involvement
fication of ligaments and entheses, although in AS this of atypical sites). Therefore, given the lack of studies on
process is thought to occur through different, inflam- the medical treatment of DISH, suggested treatments for
matory mechanisms. DISH can be distinguished from OA can be cautiously adopted. Such approaches include
AS by the absence of SIJ involvement, the appearance evaluation of activities of daily living; instruction in joint
and angle of projection from the vertebrae of the osteo- protection techniques and use of physiotherapy; use of
phytes or syndesmophytes, the older age at presentation, oral NSAIDs, analgesics, tramadol and, when there is
the absence of apophyseal joint obliteration, the lack of evidence of OA lesions, chondroitin and glucosamine;
association with HLA‑B27 and the lower degree of pain and intra-articular corticosteroid injections. In patients
and discomfort.6,95 with OA, for some joints, topical application of capsaicin
and NSAIDs might be preferred over oral NSAIDs.101 In
Treatment fact, the use of locally acting NSAIDs could be as effec-
Approach to management tive as systemic therapy, at least in patients with knee
Data regarding therapeutic interventions in DISH are OA, and thus might be useful for the relief of pain in
very limited. Although patients with DISH are presum- the peripheral joints and the entheses in patients with
ably included in OA therapeutic trials, no reported thera- DISH.102 Painful entheses might also benefit from soft
peutic studies have specifically focused on this group of protections or local corticosteroid injections, although
patients. Interventions aimed at preventing the condi- no studies have yet investigated such approaches in
tion or arresting its progression are hampered by the long patients with DISH.
time period required for the development of the ver-
tebral bony bridges. It has been suggested that it takes Prevention and management of comorbidities
approximately 10 years from the start of the ossification The metabolic and constitutional abnormalities fre-
to its full radiological expression.96 In this regard, the quently observed in patients with DISH deserve attention
for their effect on the risk of cardiovascular disease. symmetrical peripheral enthesopathies (in the absence of
Thus, physical activity, low intake of saturated fat and of spinal involvement) can be the only manifestation of the
carbohydrates, and weight reduction should be encour- condition. Furthermore, very little is known about
aged. Moreover, such strategies should help to reduce the aetiology, pathogenesis and associated conditions
hyperinsulinaemia, which is thought to have a role in the that, in our opinion, should be incorporated in future
pathogenesis of DISH. In addition, hypertensive patients definitions of the disease. Thus, we think that new diag-
with DISH should try to avoid medications that might nostic criteria should be established and validated, with
increase insulin resistance, such as thiazide diuretics and particular emphasis on early manifestation.
β‑adrenergic antagonists (β-blockers), and preferentially It is unlikely that the excessive bone formation can be
select medications that improve insulin resistance, such reversed, but with more knowledge it might be prevented.
as angiotensin-converting enzyme (ACE) inhibitors, To this end, large-scale epidemiological studies address-
calcium channel blockers and α‑adrenergic antagonists.103 ing the full clinical spectrum of DISH and its preva
lence, natural course and outcome are needed. Moreover,
Surgery and complications exploration of the factors responsible for bone formation,
In the absence of traumatic fractures, surgical spinal inter- together with familial aggregation studies and the identi-
ventions are rarely needed in patients with DISH, except fication of genetic markers (haplotypes) associated with
in cases with severe spinal stenosis or large cervical osteo- DISH, might help to uncover the molecular basis of the
phytes. Two small case series have reported that patients ligamentous and entheseal ossification that characterizes
with large anterior cervical osteophytes causing dysphagia the condition. Such understanding might pave the way
or airway obstruction, who failed medical therapy, might to more targeted and effective therapies in the future.
benefit from surgical resection of the osteophytes.104,105 So, instead of merely symptomatic relief, future research
Finally, patients and physicians should be aware of, may offer a disease-modifying therapeutic approach to
and try to prevent, complications such as aspiration patients with DISH.
pneumonia, difficulties in endotracheal intubation or
upper gastrointestinal endoscopy, and accidental falls. Conclusions
Prevention of heterotropic ossification using NSAIDs, DISH is a condition characterized by new bone forma-
vitamin K antagonists or irradiation should be considered tion, and constitutional and metabolic abnormalities.
in patients undergoing orthopaedic surgery (Box 1).106,107 Little is known about its pathogenesis, and suitable thera
peutic approaches are unclear. A more comprehensive
Suggestions for future research definition of DISH, that preferably includes patients with
DISH is a clinical and radiological entity usually diag- early phase disease, and prospective studies in patients
nosed on radiographic grounds only. Nonetheless, DISH prone to develop the condition are needed to advance
should be considered an extensive proliferative musculo our understanding of this condition.
skeletal disease associated with clinical and metabolic
derangements. Owing to the limitations of the current Review criteria
definitions and classification criteria, the condition The articles cited in this Review were selected from the
cannot be diagnosed in its early stages. As a result, effec- authors’ personal library of articles on DISH. Selections
tive treatment to arrest or slow the progression of the were made on the basis of the expert opinions of
disease has never been investigated. We believe that large the authors.
1. Forestier, J. & Rotes-Querol, J. Senile ankylosing skeletal hyperostosis of the cervical spine: an 14. Rogers, J. & Waldron, T. DISH and the monastic
hyperostosis of the spine. Ann. Rheum. Dis. 9, underestimated cause of dysphagia and airway way of life. Int. J. Osteoarchaeol. 11, 357–365
321–330 (1950). obstraction. Spine J. 11, 1058–1067 (2011). (2001).
2. Van der Merwe, A. E., Maat, G. J. & Watt, I. 8. Weisz, G. M., Matucci-Cerinic, M., Lippi, D. & 15. Ullrich, H. [Goethe’s skull and skeleton] 60,
Diffuse idiopathic skeletal hyperostosis: Albury, W. R. The ossification diathesis in the 341–368 (2002).
Diagnosis in a palaeopathological context. medici family: DISH and other features. 16. Kiss, C. et al. Prevalence of diffuse idiopathic
Homo 63, 202–215 (2012). Rheumatol. Int. 31, 1649–1652 (2011). skeletal hyperostosis in Budapest, Hungary.
3. Resnick, D. & Niwayama, G. Radiographic and 9. Verlaan, J. J., Oner, F. C. & Maat, G. J. Diffuse Rheumatology (Oxford) 41, 1335–1336 (2002).
pathologic features of spinal involvement in idiopathic skeletal hyperostosis in ancient 17. Westerveld, L. A., van Ufford, H. M.,
diffuse idiopathic skeletal hyperostosis (DISH). clergymen. Eur. Spine J. 16, 1129–1135 (2007). Verlaan, J. J. & Oner, F. C. The prevalence of
Radiology 119, 559–568 (1976). 10. Chhem, R. K., Schmit, P. & Fauré, C. Did diffuse idiopathic skeletal hyperostosis in an
4. Beyeler, C. et al. Diffuse idiopathic skeletal Ramesses II really have ankylosing spondylitis? outpatient population in the Netherlands.
hyperostosis (DISH) of the elbow: A cause of A reappraisal. Can. Assoc. Radiol. J. 55, J. Rheumatol. 35, 1635–1638 (2008).
elbow pain? A controlled study. Br. J. Rheumatol. 211–217 (2004). 18. Weinfeld, R. M., Olson, P. N., Maki, D. D. &
31, 319–323 (1992). 11. Crubézy, E. & Trinkaus, E. Shanidar 1: a case of Griffiths, H. J. The prevalence of diffuse
5. Mader, R., Novofestovski, I., Adawi, M. & Lavi, I. hyperostotic disease (DISH) in the middle idiopathic skeletal hyperostosis (DISH) in two
Metabolic syndrome and cardiovascular risk in Paleolithic. Am. J. Phys. Anthropol. 89, 411–420 large american midwest metropolitan hospital
patients with diffuse idiopathic skeletal (1992). populations. Skeletal Radiol. 26, 222–225
hyperostosis. Semin. Arthritis Rheum. 38, 12. Giuffra, V. et al. Diffuse idiopathic skeletal (1997).
361–365 (2009). hyperostosis in the Medici, Grand Dukes of 19. Holton, K. F. et al. Diffuse idiopathic skeletal
6. Mader, R. et al. Extraspinal manifestations of Florence (XVI century). Eur. Spine J. hyperostosis and its relation to back pain among
diffuse idiopathic skeletal hyperostosis. 19 (Suppl. 2), S103–S107 (2010). older men: The MrOS study. Semin. Arthritis
Rheumatology 48, 1478–1481 (2009). 13. Waldron, T. DISH at merton priory: evidence for Rheum. 41, 131–138 (2011).
7. Verlaan, J. J., Boswijk, F. L., de Ru, J. A., a “new” occupational disease? BMJ 291, 20. Bray, G. A. & Bellanger, T. Epidemiology, trends,
Dhert, W. J. & Oner, F. C. Diffuse idiopathic 1762–1763 (1985). and morbidities of obesity and the metabolic
syndrome. Endocrine 29, 109–117 (2006). 40. Whang, P. G. et al. The management of spinal idiopathic skeletal hyperostos: A controlled
21. Mader, R. & Lavi, I. Diabetes mellitus and injuries in patients with ankylosing spondylitis or study. J. Rheumatol. 23, 672–676 (1996).
hypertension as risk factors for early diffuse diffuse idiopathic skeletal hyperostosis: A 59. Akune, T. et al. Insulin secretory response is
idiopathic skeletal hyperostosis (DISH). comparison of treatment methods and clinical positively associated with the extent of
Osteoarthritis Cartilage 17, 825–828 (2009). outcomes. J. Spinal Disord. Tech. 22, 77–85 ossification of the posterior longitudinal
22. Mader, R. Diffuse idiopathic skeletal (2009). ligament of the spine. J. Bone Joint Surg. 83A,
hyperostosis: a distinct clinical entity. Isr. Med. 41. Westerveld, L. A., van Bemmel, J. C., 1537–1544 (2001).
Assoc. J. 5, 506–508 (2003). Dhert, W. J., Oner, F. C. & Verlaan, J. J. Clinical 60. Kiss, C., Szilagyi, M., Paksy, A. & Poor, G.
23. Fornasier, V. L., Littlejohn, G. O., Urowitz, M. B., outcome after traumatic spinal fractures in Risk factors for diffuse idiopathic skeletal
Keystone, E. C. & Smythe, H. A. Spinal entheseal patients with ankylosing spinal disorders hyperostosis: a case control study.
new bone formation: the early changes of spinal compared with control patients. Spine J. http:// Rheumatology (Oxford) 41, 27–30 (2002).
diffuse idiopathic skeletal hyperostosis. www.doi.org/10.1016/j.spinee.2013.06.038. 61. Sarzi-Puttini, P. & Atzeni, F. New developments in
J. Rheumatol. 10, 934–947 (1983). 42. Littlejohn, J. O., Urowitz, M. B., Smythe, H. A. & our understanding of DISH (diffuse idiopathic
24. Belanger, T. A. & Rowe, D. E. Diffuse idiopathic Keystone, E. C. Radiographic features of the skeletal hyperostosis). Curr. Opin. Rheumatol.
skeletal hyperostosis: musculoskeletal hand in diffuse idiopathic skeletal hyperostosis 16, 287–292 (2004).
manifestations. J. Am. Acad. Orthop. Surg. 9, (DISH). Radiology 140, 623–629 (1981). 62. Miyazawa, N. & Akiyama, I. Diffuse idiopathic
258–267 (2001). 43. Beyeler, C. et al. Diffuse idiopathic skeletal skeletal hyperostosis associated with risk
25. Mader, R. Clinical manifestations of diffuse hyperostosis (DISH) of the shoulder. A cause of factors for stroke. Spine 31, E225–E229
idiopathic skeletal hyperostosis of the cervical shoulder pain? Br. J. Rheumatol. 29, 349–353 (2006).
spine. Semin. Arthritis Rheum. 32, 130–135 (1990). 63. Forestier, J. & Lagier, R. Ankylosing
(2002). 44. Utsinger, P. D., Resnick, D. & Shapiro, R. Diffuse hyperostosis of the spine. Clin. Orthop. 74,
26. Di Girolamo, C. et al. Intervertebral disc lesions skeletal abnormalities in Forestier’s disease. 65–83 (1971).
in diffuse idiopathic skeletal hyperostosis Arch. Intern. Med. 136, 763–768 (1976). 64. Sencan, D., Elden, H., Nacitrahan, V., Sencan, M.
(DISH). Clin. Exp. Rheumatol. 19, 310–312 45. Schlapbach, P. et al. The prevalence of palpable & Kaptanoglu, E. The prevalence of diffuse
(2001). finger joints nodules in diffuse idiopathic idiopathic skeletal hyperostosis in patients with
27. Hutton, C. DISH…. a state not a disease? skeletal hyperostosis (DISH). A controlled study. diabetes mellitus. Rheumatol. Int. 25, 518–521
[editorial]. Br. J. Rheumatol. 28, 277–280 (1989). Br. J. Rheumatol. 31, 531–534 (1992). (2005).
28. Utsinger, P. D. Diffuse idiopathic skeletal 46. Littlejohn, J. O. & Urowitz, M. B. Peripheral 65. Denko, C. W. & Malemud, C. J. Body mass index
hyperostosis. Clin. Rheum. Dis. 11, 325–351 enthesopathy in diffuse idiopathic skeletal and blood glucose: correlations with serum
(1985). hyperostosis (DISH): a radiologic study. insulin, growth hormone, and insulin-like growth
29. Resnick, D. et al. Diffuse idiopathic skeletal J. Rheumatol. 9, 568–572 (1982). factor‑1 levels in patients with diffuse idiopathic
hyperostosis (DISH) [ankylosing hyperostosis of 47. Resnick, D., Shaul, S. R. & Robins, J. M. skeletal hyperostosis (DISH). Rheumatol. Int. 26,
Forestier and Rotes-Querol]. Semin. Arthritis Diffuse idiopathic skeletal hyperostosis (DISH): 292–297 (2006).
Rheum. 7, 153–187 (1978). Forestier’s disease with extraspinal 66. Littlejohn, G. O. & Smythe, H. A. Marked
30. Mata, S. et al. A controlled study of diffuse manifestations. Radiology 115, 513–524 hyperinsulinemia after glucose challenge in
idiopathic skeletal hyperostosis. Clinical (1975). patients with diffuse idiopathic skeletal
features and functional status. Medicine 76, 48. Haller, J. et al. Diffuse idiopathic skeletal hyperostosis. J. Rheumatol. 8, 965–968
104–117 (1997). hyperostosis: diagnostic significance of (1981).
31. Schlapbach, P. et al. Diffuse idiopathic skeletal radiographic abnormalities of the pelvis. 67. Eckertova, M. et al. Impaired insulin secretion
hyperostosis (DISH) of the spine: A cause of Radiology 172, 835–839 (1989). and uptake in patients with diffuse idiopathic
back pain? A controlled study. Br. J. Rheumatol. 49. Shehab, D., Elgazzar, A. H. & Collier, B. D. skeletal hyperostosis. Endocr. Regul. 43,
28, 299–303 (1989). Heterotopic ossification. J. Nucl. Med. 43, 149–155 (2009).
32. Mader, R. et al. Non articular tenderness and 346–353 (2002). 68. Mueller, M. B. et al. Insulin is essential for
functional status in patients with diffuse 50. Gorman, C., Jawad, A. S. M. & Chikanza, I. in vitro chondrogenesis of mesenchymal
idiopathic skeletal hyperostosis. J. Rheumatol. A family with diffuse idiopathic hyperostosis. progenitor cells and influences chondrogenesis
37, 1911–1916 (2010). Ann. Rheum. Dis. 64, 1794–1795 (2005). in a dose-dependent manner. Int. Orthop. 37,
33. Olivieri, I. et al. Diffuse idiopathic skeletal 51. Burges-Armas, J. et al. Ectopic calcification 153–158 (2013).
hyperostosis may give the typical postural among families in the Azores: clinical and 69. Ohlsson, C., Bengtsson, B. A., Isaksson, O. G. P.,
abnormalities of advanced ankylosing spondylitis. radiological manifestations in families with Andereassen, T. T. & Slootweg, M. C. Growth
Rheumatology 46, 1709–1711 (2007). diffuse idiopathic skeletal hyperostosis and hormone and bone. Endocrine Rev. 19, 55–79
34. Baraliakos, X., Listing, J., Buschmann, J., von der chondrocalcinosis. Arthritis Rheum. 54, (1998).
Recke, A. & Braun, J. A comparison of new bone 1340–1349 (2006). 70. Vetter, U. et al. Human fetal and adult
formation in patients with ankylosing spondylitis 52. Kranenburg, H. C. et al. The dog as an animal chondrocytes. Effect of insulinlike growth
and patients with diffuse idiopathic skeletal model for DISH? Eur. Spine J. 19, 1325–1329 factors I and II, insulin, and growth hormone on
hyperostosis. A retrospective cohort study over (2010). clonal growth. J. Clin. Invest. 77, 1903–1908
six years. Arthritis Rheum. 64, 1127–1133 53. Havelka, S. et al. Are DISH and OPLL genetically (1986).
(2012). related? Ann. Rheum. Dis. 60, 902–903 (2001). 71. Denko, C. W., Boja, B. & Moskowitz, R. W. Growth
35. Belanger, T. A. & Rowe, D. E. Diffuse idiopathic 54. Tsukahara, S. et al. COL6A1, the candidate gene factors, insulin-like growth factor‑1 and growth
skeletal hyperostosis: musculoskeletal for ossification of the posterior longitudinal hormone, in synovial fluid and serum of patients
manifestations. J. Am. Acad. Orthop. Surg. 9, ligament, is associated with diffuse idiopathic with rheumatic disorders. Osteoarthritis Cartilage
258–267 (2001). skeletal hyperostosis in Japanese. Spine 30, 4, 245–249 (1996).
36. Laroche, M. et al. Lumbar and cervical stenosis. 2321–2324 (2005). 72. Denko, C. W., Boja, B. & Malemud, C. J. Intra-
Frequency of the association, role of the 55. Shingyouchi, O., Nagahama, A. & Niida, M. erythrocyte deposition of growth hormone in
ankylosing hyperostosis. Clin. Rheumatol. 11, Ligamentous ossification of the cervical spine in rheumatic diseases. Rheumatol. Int. 23, 11–14
533–535 (1992). the late middle-aged Japanese men. Its relation (2003).
37. Liu, P. et al. Spinal trauma in mainland China to body mass index and glucose metabolism. 73. el Miedany, Y. M., Wassif, G. & el Baddini, M.
from 2001 to 2007: An epidemiological study Spine 21, 2474–2478 (1996). Diffuse idiopathic skeletal hyperostosis (DISH):
based on a nationwide database. Spine (Phila Pa 56. Littlejohn, G. O. Insulin and new bone formation is it of vascular etiology? Clin. Exp. Rheumatol.
1976) 37, 1310–1315 (2012). in diffuse idiopathic skeletal hyperostosis. Clin. 18, 193–200 (2000).
38. Caron, T. et al. Spine fractures in patients with Rheumatol. 4, 294–300 (1985). 74. Nesher, G. & Zuckner, J. Rheumatologic
ankylosing spinal disorders. Spine (Phila Pa 57. Denko, C. W., Boja, B. & Moskowitz, R. W. complications of vitamin A and retinoids. Semin.
1976) 35, E458–E464 (2010). Growth promoting peptides in osteoarthritis Arthritis Rheum. 24, 291–296 (1995).
39. Westerveld, L. A., Verlaan, J. J. & Oner, F. C. and diffuse idiopathic skeletal hyperostosis 75. Abiteboul, M., Arlet J., Sarrabay, M. A.,
Spinal fractures in patients with ankylosing —insulin, insulin-like growth factor‑I, growth Mazières, B. & Thouvenot, J. P. Etude du
spinal disorders: A systematic review of the hormone. J. Rheumatol. 21, 1725–1730 metabolisme de la vitamine A au cours de la
literature on treatment, neurological status and (1994). maladie hyperostosique de Forestier et Rote’s-
complications. Eur. Spine J. 18, 145–156 58. Vezyroglou, G., Mitropoulos, A., Kyriazis, N. & Querol. Rev. Rhum. Ed. Fr. 53, 143–145
(2009). Antoniadis, C. A metabolic syndrome in diffuse (1986).
76. Ling, T. C., Parkin, G., Islam, J., Seukeran, D. C. & synthesis of bone morphogenetic proteins of skeletal hypertrophy and degenerative disk
Cunliffe, W. J. What is the cumulative effect of spinal ligament cells derived from patients with disease. J. Chiropr. Med. 11, 293–299 (2012).
long-term, low dose isotretinoin on the ossification of the posterior longitudinal 100. El Garf, A. & Khater, R. Diffuse idiopathic skeletal
development of DISH? Br. J. Dermatol. 144, ligaments. Bone 33, 475–484 (2003). hyperostosis (DISH): a clinicopathological study
630–632 (2001). 88. Ohishi, H. et al. Role of prostaglandin I2 in the of the disease pattern in Middle Eastern
77. Aeberli, D., Schett, G., Eser, P., Seitz, M. & gene expression induced by mechanical stress populations. J. Rheumatol. 11, 804–807 (1984).
Villiger, P. M. Serum Dkk‑1 levels of DISH in spinal ligament cells derived from patients 101. Hochberg, M. C. et al. American College of
patients are not different from healthy controls. with ossification of the posterior longitudinal Rheumatology recommendations for the use
Joint Bone Spine 78, 422–423 (2011). ligament. J. Pharmacol. Exp. Ther. 305, 818–824 of nonpharmacologic and pharmacologic
78. Daoussis, D. & Andonopoulos, A. P. The emerging (2003). therapies in osteoarthritis of the hand, hip,
role of Dickkopf‑1 in bone biology: is it the main 89. Iwasawa, T. et al. Pathophysiological role of and knee. Arthritis Care Res. 64, 465–474
switch controlling bone and joint remodeling? endothelin in ectopic ossification of human (2012).
Semin. Arthritis Rheum. 41, 170–177 (2011). spinal ligaments induced by mechanical stress. 102. Roth, S. H. & Shainhouse, J. Z. Efficacy and
79. Senolt, L. et al. Low circulating Dickkopf‑1 and its Calcif. Tissue Int. 79, 422–430 (2006). safety of a topical diclofenac solution (pennsaid)
link with severity of spinal involvement in diffuse 90. Kasperk, C. H. et al. Endothelin‑1 is a potent in the treatment of primary osteoarthritis of the
idiopathic skeletal hyperostosis. Ann. Rheum. regulator of human bone cell metabolism. Calcif. knee: a randomized, double-blind, vehicle-
Dis. 71, 71–74 (2012). Tissue Int. 60, 368–374 (1997). controlled clinical trial. Arch. Intern. Med. 164,
80. Mader, R. & Verlaan, J. J. Bone: Exploring factors 91. Carile, L., Verdone, F., Aiello, A. & Buongusto, G. 2017–2023 (2004).
responsible for bone formation in DISH. Nat. Diffuse idiopathic skeletal hyperostosis and 103. Lithell, H. O. L. Effect of antihypertensive drugs
Rev. Rheumatol. 8, 10–12 (2011). situs viscerum inversus. J. Rheumatol. 16, on insulin, glucose, and lipid metabolism.
81. Kosaka, T., Imakiire, A., Mizuno, F. & 1120–1122 (1989). Diabetes Care 14, 203–209 (1991).
Yamamoto, K. Activation of nuclear factor κB at 92. Smythe, H. A. The mechanical pathogenesis of 104. Carlson, M. L., Archibald, D. J., Graner, D. E. &
the onset of ossification of the spinal ligaments. generalized osteoarthritis. J. Rheumatol. Kasperbauer, J. L. Surgical management of
J. Orthop. Sci. 5, 572–578 (2000). 10 (Suppl. 9), 11–12 (1983). dysphagia and airway obstruction in patients
82. Inaba, T. et al. Enhanced expression of platelet- 93. Arlet, J. & Mazieres, B. La maladie with prominent ventral cervical osteophytes.
derived growth factor-β receptor by high glucose. hyperostosique. Rev. Mdd. Interne. 6, 553–564 Dysphagia 26, 34–40 (2011).
Involvement of platelet-derived growth factor in (1985). 105. Urrutia, J. & Bono, C. M. Long-term results of
diabetic angiopathy. Diabetes 45, 507–512 94. Mader, R. et al. Developing new classification surgical treatment of dysphagia secondary to
(1996). criteria for diffuse idiopathic skeletal cervical diffuse idiopathic skeletal hyperostosis.
83. Pfeiffer, A., Middelberg-Bisping, K., Drewes, C. hyperostosis: back to square one. Rheumatology Spine J. 9, e13–e17 (2009).
& Schatz, H. Elevated plasma levels of (Oxford) 52, 326–330 (2013). 106. Guillemin, F., Mainard, D., Rolland, H. &
transforming growth factor-β1 in NIDDM. 95. Olivieri, I. et al. Diffuse idiopathic skeletal Delagoutte, J. P. Antivitamin K prevents
Diabetes Care 19, 1113–1117 (1996). hyperostosis: differentiation from ankylosing heterotopic ossification after hip arthroplasty in
84. Kon, T. et al. Bone morphogenetic protein‑2 spondylitis. Curr. Rheumatol. Rep. 11, 321–328 diffuse idiopathic skeletal hyperostosis: a
stimulates differentiation of cultured spinal (2009). retrospective study in 67 patients. Acta Orthop.
ligament cells from patients with ossification of 96. Mader, R. Diffuse idiopathic skeletal hyperostosis: Scand. 66, 123–126 (1995).
the posterior longitudinal ligament. Calcif. Tissue isolated involvement of cervical spine in a young 107. Knelles, D. et al. Prevention of heterotopic
Int. 60, 291–296 (1997). patient. J. Rheumatol. 31, 620–621 (2004). ossification after total hip replacement: a
85. Tanaka, H. et al. Involvement of bone 97. Al-Herz, A., Snip, J. P., Clark, B. & Esdaile, J. M. prospective, randomized study using
morphogenic protein‑2 (BMP‑2) in the Exercise therapy for patients with diffuse acetylsalicylic acid, indomethacin and fractional
pathological ossification process of the spinal idiopathic skeletal hyperostosis. Clin. or single-dose irradiation. J. Bone Joint Surg. Br.
ligament. Rheumatology 40, 1163–1168 (2001). Rheumatol. 27, 207–210 (2008). 79, 596–602 (1997).
86. Zebboudj, A. F., Imura, M. & Bostrom, K. Matrix 98. Troyanovich, S. J. & Buettner, M. A structural
GLA protein, a regulatory protein for bone chiropractic approach to the management of Author contributions
morphogenetic protein‑2. J. Biol. Chem. 8, diffuse idiopathic skeletal hyperostosis. All authors made substantial contributions to
4388–4394 (2002). J. Manipulative Physiol. Ther. 26, 202–206 (2003). discussions of content, writing, and reviewing/
87. Tanno, M., Furukawa, K. I., Ueyama, K., 99. Roberts, J. A., Tristy, M. & Wolfe, M. A. editing the manuscript before submission. In
Harata, S. & Motomura, S. Uniaxial cyclic Chiropractic management of a veteran with lower addition, R. Mader and J.‑J. Verlaan researched data
stretch induces osteogenic differentiation and back pain associated with diffuse idiopathic for the article.